Literature DB >> 10999816

Phenotypic diversity and testosterone-induced normalization of mutant L712F androgen receptor function in a kindred with androgen insensitivity.

P M Holterhus1, G H Sinnecker, O Hiort.   

Abstract

Molecular causes of phenotypic diversity in androgen insensitivity syndrome, occurring even in the same family, have rarely been identified. We report on a family with four affected individuals, three brothers (B1-3) and their uncle, displaying strikingly different external genitalia: B1, ambiguous; B2, severe micropenis; B3, slight micropenis; and uncle, micropenis and penoscrotal hypospadias. All had been assigned a male gender. We detected the same L712F mutation of the androgen receptor (AR) gene in each subject. Methyltrienolone binding on cultured genital skin fibroblasts of B2 suggested moderate impairment of the ligand-binding domain [maximal binding capacity, 38.2 fmol/mg protein (normal); Kd, 0.21 nmol/L; normal range, 0.03-0.13 nmol/L]. In trans-activation assays, the mutant 712F-AR showed considerable deficiency at low concentrations of testosterone (0.01-0.1 nmol/L) or dihydrotestosterone (0.01 nmol/L). Remarkably, this could be fully neutralized by testosterone concentrations greater than 1.0 nmol/L. Hence, the 712F-AR could switch its function from subnormal to normal within the physiological concentration range of testosterone. This was reflected by an excellent response to testosterone therapy in B1, B2, and the uncle. Taking into account the well documented individual and time-dependent variation in testosterone concentration in early fetal development, our observations clearly illustrate the potential impact of varying ligand concentrations for distinct cases of phenotypic variability in androgen insensitivity syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999816     DOI: 10.1210/jcem.85.9.6812

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations.

Authors:  P M Holterhus; R Werner; U Hoppe; J Bassler; E Korsch; M B Ranke; H G Dörr; O Hiort
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

2.  Isolated micropenis reveals partial androgen insensitivity syndrome confirmed by molecular analysis.

Authors:  Amrit Bhangoo; Francoise Paris; Pascal Philibert; Francoise Audran; Svetlana Ten; Charles Sultan
Journal:  Asian J Androl       Date:  2010-03-22       Impact factor: 3.285

3.  Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone.

Authors:  Emily B Askew; Robert T Gampe; Thomas B Stanley; Jonathan L Faggart; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

4.  Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome.

Authors:  Mahesh Appari; Ralf Werner; Lutz Wünsch; Gunnar Cario; Janos Demeter; Olaf Hiort; Felix Riepe; James D Brooks; Paul-Martin Holterhus
Journal:  J Mol Med (Berl)       Date:  2009-03-30       Impact factor: 4.599

5.  Androgen receptor function links human sexual dimorphism to DNA methylation.

Authors:  Ole Ammerpohl; Susanne Bens; Mahesh Appari; Ralf Werner; Bernhard Korn; Stenvert L S Drop; Frans Verheijen; Yvonne van der Zwan; Trevor Bunch; Ieuan Hughes; Martine Cools; Felix G Riepe; Olaf Hiort; Reiner Siebert; Paul-Martin Holterhus
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

6.  Cytogenetics and etiology of ambiguous genitalia in 120 pediatric patients.

Authors:  Angham Al-Mutair; M Anwar Iqbal; Nadia Sakati; Abdullah Ashwal
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.